医学
淋巴瘤
回顾性队列研究
内科学
外科
肿瘤科
化疗
临床试验
梅德林
不利影响
作者
Mark R. Dowling,Edward R. Scheffer Cliff,Anthony Jeffrey,Catelyn Cashion,Stephen Boyle,Jian Li,Thomas Buss,R. MacDonald,Anastasia Edelkina,Hamish W Scott,Nicole O'Leary,Michelle Wendy Keir,Safia Belbachir,D. Westerman,Constantine S. Tam,P. Joy Ho,Simon J Harrison,Allison Barraclough,Shafqat Inam,Emily Blyth
出处
期刊:Blood
[Elsevier BV]
日期:2026-02-17
卷期号:147 (19): 2272-2277
标识
DOI:10.1182/blood.2025032307
摘要
ABSTRACT: In this retrospective analysis of 584 patients who received chimeric antigen receptor T-cell therapy for large B-cell lymphoma at 6 Australian centers, no association was found between time of infusion and outcome, accounting for confounders, suggesting minimal clinical impact of chronobiology in this setting.
科研通智能强力驱动
Strongly Powered by AbleSci AI